发布求助
文献互助 智能选刊 最新文献

The Brown University Psychopharmacology Update最新文献

筛选
英文 中文
Cyproheptadine-prazosin combination reduces drinking in AUD patients 赛庚啶-普拉唑嗪联合疗法可减少 AUD 患者的饮酒量
The Brown University Psychopharmacology Update Pub Date : 2024-06-27 DOI: 10.1002/pu.31192
{"title":"Cyproheptadine-prazosin combination reduces drinking in AUD patients","authors":"","doi":"10.1002/pu.31192","DOIUrl":"https://doi.org/10.1002/pu.31192","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 8","pages":"7"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141488300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Your Medication Information 您的用药信息
The Brown University Psychopharmacology Update Pub Date : 2024-06-27 DOI: 10.1002/pu.31197
{"title":"Your Medication Information","authors":"","doi":"10.1002/pu.31197","DOIUrl":"https://doi.org/10.1002/pu.31197","url":null,"abstract":"<p>Lithium (generic) — Eskalith, Eskalith CR, Lithobid (brand)</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 8","pages":"9-10"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141488299","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Review identifies factors associated with response to psilocybin 审查确定了与对迷幻药反应有关的因素
The Brown University Psychopharmacology Update Pub Date : 2024-06-27 DOI: 10.1002/pu.31193
{"title":"Review identifies factors associated with response to psilocybin","authors":"","doi":"10.1002/pu.31193","DOIUrl":"https://doi.org/10.1002/pu.31193","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 8","pages":"7-8"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141488948","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Second Phase 3 trial shows benefit of xanomeline-trospium in schizophrenia 第二项三期试验显示，赛诺梅林-曲司泮能为精神分裂症患者带来益处
The Brown University Psychopharmacology Update Pub Date : 2024-06-27 DOI: 10.1002/pu.31190
{"title":"Second Phase 3 trial shows benefit of xanomeline-trospium in schizophrenia","authors":"","doi":"10.1002/pu.31190","DOIUrl":"https://doi.org/10.1002/pu.31190","url":null,"abstract":"<p>A 5-week trial has found that the combination of the muscarinic receptor agonist xanomeline and the peripheral muscarinic antagonist trospium significantly reduced symptoms of schizophrenia in adults. The xanomeline-trospium combination was well-tolerated, with no significant difference from placebo in extrapyramidal symptoms or weight gain.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 8","pages":"4-5"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141488946","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Appropriate use of anticholinergics 适当使用抗胆碱能药物
The Brown University Psychopharmacology Update Pub Date : 2024-06-27 DOI: 10.1002/pu.31188
Y. W. Francis Lam Pharm.D., FCCP
{"title":"Appropriate use of anticholinergics","authors":"Y. W. Francis Lam Pharm.D., FCCP","doi":"10.1002/pu.31188","DOIUrl":"https://doi.org/10.1002/pu.31188","url":null,"abstract":"<p>Drug-induced movement disorders, including drug-induced parkinsonism, dystonia, akathisia, and tardive dyskinesia, are common adverse effects of dopamine receptor blockers, such as antipsychotics (especially first-generation agents). Anticholinergic medications are commonly used to treat extrapyramidal symptoms and drug-induced movement disorders. However, the multiple etiologies of the various types of abnormal movement disorders suggest that even though their presenting symptoms might be similar, different drug-induced movement disorders should not be treated with the same medication.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 8","pages":"2-3"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141488944","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjunctive aticaprant reduces symptoms in patients with depression 阿替卡朋辅助治疗可减轻抑郁症患者的症状
The Brown University Psychopharmacology Update Pub Date : 2024-06-27 DOI: 10.1002/pu.31194
{"title":"Adjunctive aticaprant reduces symptoms in patients with depression","authors":"","doi":"10.1002/pu.31194","DOIUrl":"https://doi.org/10.1002/pu.31194","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 8","pages":"8"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141488949","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Low dose of esketamine after childbirth helps mothers at risk of depression 产后服用小剂量艾司氯胺酮有助于降低母亲患抑郁症的风险
The Brown University Psychopharmacology Update Pub Date : 2024-06-27 DOI: 10.1002/pu.31189
{"title":"Low dose of esketamine after childbirth helps mothers at risk of depression","authors":"","doi":"10.1002/pu.31189","DOIUrl":"https://doi.org/10.1002/pu.31189","url":null,"abstract":"<p>Women with prenatal depressive symptoms who received a single low dose of esketamine shortly after childbirth showed a substantially lower incidence of a major depressive episode at 42 days postpartum than women receiving placebo, a new study has found. Neuropsychiatric adverse events occurred more frequently in the esketamine group, but no severe adverse events were reported.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 8","pages":"3-4"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141488945","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-hospital initiation of medication for AUD reduces rehospitalization 入院后开始使用药物治疗 AUD 可减少再次入院率
The Brown University Psychopharmacology Update Pub Date : 2024-06-27 DOI: 10.1002/pu.31191
{"title":"Post-hospital initiation of medication for AUD reduces rehospitalization","authors":"","doi":"10.1002/pu.31191","DOIUrl":"https://doi.org/10.1002/pu.31191","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 8","pages":"7"},"PeriodicalIF":0.0,"publicationDate":"2024-06-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141488947","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cohort study finds medications for ADHD reduce mortality risk 队列研究发现治疗多动症的药物可降低死亡风险
The Brown University Psychopharmacology Update Pub Date : 2024-06-04 DOI: 10.1002/pu.31178
{"title":"Cohort study finds medications for ADHD reduce mortality risk","authors":"","doi":"10.1002/pu.31178","DOIUrl":"https://doi.org/10.1002/pu.31178","url":null,"abstract":"<p>Children and adults with attention-deficit hyperactivity disorder (ADHD) who initiated medication treatment had significantly lower 2-year mortality rates compared with ADHD patients who did not initiate medication, a cohort study has found. The difference in mortality rates was greater for deaths due to unnatural causes such as accidental poisoning and suicide.</p>","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 7","pages":"3"},"PeriodicalIF":0.0,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141245472","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjunctive esketamine in women having cesarean has early effect on depressive symptoms 对剖腹产妇女辅助使用艾司氯胺酮对抑郁症状有早期疗效
The Brown University Psychopharmacology Update Pub Date : 2024-06-04 DOI: 10.1002/pu.31182
{"title":"Adjunctive esketamine in women having cesarean has early effect on depressive symptoms","authors":"","doi":"10.1002/pu.31182","DOIUrl":"https://doi.org/10.1002/pu.31182","url":null,"abstract":"","PeriodicalId":22275,"journal":{"name":"The Brown University Psychopharmacology Update","volume":"35 7","pages":"8"},"PeriodicalIF":0.0,"publicationDate":"2024-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141245623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信